{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:12:11Z","timestamp":1791396731984,"version":"4.3.3"},"reference-count":61,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s301225","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:21:40Z","timestamp":1617754900000},"page":"957-970","source":"Crossref","is-referenced-by-count":46,"title":["Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II\/III Studies"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"\u00c1gota","family":"Barab\u00e1ssy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1roly","family":"Acsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Laszlovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie R","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/PROM.S42735","volume":"5","author":"Haddad","year":"2014","journal-title":"Patient Relat Outcome Meas"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00004850-199501005-00008","volume":"9","author":"Bebbington","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1176\/ps.49.2.196","volume":"49","author":"Cramer","year":"1998","journal-title":"Psychiatr Serv"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/schbul\/sbj075","volume":"32","author":"Velligan","year":"2006","journal-title":"Schizophr Bull"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40263-020-00713-9","volume":"34","author":"Yaegashi","year":"2020","journal-title":"CNS Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4088\/JCP.0607e14","volume":"68","author":"Weiden","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0269881110391123","volume":"25","author":"Barnes","year":"2011","journal-title":"J Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.psc.2007.04.002","volume":"30","author":"Byerly","year":"2007","journal-title":"Psychiatr Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1192\/apt.bp.106.003194","volume":"13","author":"Mitchell","year":"2007","journal-title":"Adv Psychiatric Treat"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4088\/JCP.9096su1cc.04","volume":"71","author":"Goff","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1755-5949.2010.00222.x","volume":"17","author":"Nord","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"ref12","first-page":"22","volume":"14","author":"Robinson","year":"2007","journal-title":"Prim Psychiatry"},{"key":"ref13","volume-title":"Stahl\u2019s Essential Psychopharmacology","year":"2013"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S1092852917000608","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/phar.2404","volume":"40","author":"Chow","year":"2020","journal-title":"Pharmacotherapy"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2174\/1871527317666180828120256","volume":"17","author":"Mazza","year":"2018","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref17","volume-title":"Essential Pharmacology Prescriber\u2019s Guide","year":"2017"},{"key":"ref18","unstructured":"ClinicalTrials.gov. PET trial to assess the receptor occupancy of brexpiprazole in adult subjects with schizophrenia. ClinicalTrials.gov Identifier: NCT01854944. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01854944. Accessed January 24, 2020."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/npp.2017.258","volume":"43","author":"Girgis","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s00213-016-4382-y","volume":"233","author":"Girgis","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2011.05.005","volume":"131","author":"Mizrahi","year":"2011","journal-title":"Schizophr Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-25758-2_7","volume":"213","author":"Gross","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00210-008-0311-x","volume":"378","author":"Gyerty\u00e1n","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S1359-6446(05)03491-4","volume":"10","author":"Joyce","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00210-008-0308-5","volume":"378","author":"Kiss","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF03033298","volume":"6","author":"Leriche","year":"2004","journal-title":"Neurotox Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00213-012-2896-5","volume":"226","author":"Zimnisky","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","volume":"389","author":"N\u00e9meth","year":"2017","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.109.160432","volume":"333","author":"Kiss","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","volume":"135","author":"Leung","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.mp.4002066","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/PCC.v06n0101","volume":"6","author":"Miller","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/S1092852917000220","volume":"23","author":"Cutler","year":"2018","journal-title":"CNS Spectr"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e1574","DOI":"10.4088\/JCP.15m09997","volume":"76","author":"Durgam","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.schres.2016.06.030","volume":"176","author":"Durgam","year":"2016","journal-title":"Schizophr Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-016-4450-3","volume":"234","author":"Durgam","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/YIC.0000000000000110","volume":"31","author":"Durgam","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.schres.2013.11.041","volume":"152","author":"Durgam","year":"2014","journal-title":"Schizophr Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/YIC.0000000000000187","volume":"32","author":"Earley","year":"2017","journal-title":"Int Clin Psychopharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/JCP.0000000000000346","volume":"35","author":"Kane","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12888-017-1459-z","volume":"17","author":"Nasrallah","year":"2017","journal-title":"BMC Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.schres.2017.04.020","volume":"192","author":"Durgam","year":"2018","journal-title":"Schizophr Res"},{"key":"ref44","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000."},{"key":"ref45","volume-title":"ECDEU Assessment Manual for Psychopharmacology: Publication ADM","year":"1976"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4088\/JCP.v58n1205","volume":"58","author":"Marder","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1192\/S0007125000292581","volume":"163","author":"Addington","year":"1993","journal-title":"Br J Psychiatry Suppl"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"113098","DOI":"10.1016\/j.bbr.2020.113098","volume":"402","author":"Yoshida","year":"2021","journal-title":"Behav Brain Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/schbul\/sbaa063","volume":"46","author":"Takeuchi","year":"2020","journal-title":"Schizophr Bull"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S117321","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4088\/JCP.08r04210","volume":"70","author":"Kane","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852915000838","volume":"20","author":"Lohr","year":"2015","journal-title":"CNS Spectr"},{"key":"ref58","first-page":"292","volume":"4","author":"Riordan","year":"2011","journal-title":"Am Health Drug Benefits"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.7075su1c.02","volume":"70","author":"McIntyre","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1592\/phco.29.1.64","volume":"29","author":"Bostwick","year":"2009","journal-title":"Pharmacotherapy"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=68258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=68258","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:21:49Z","timestamp":1617754909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/safety-and-tolerability-of-cariprazine-in-patients-with-schizophrenia--peer-reviewed-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":61,"URL":"https:\/\/doi.org\/10.2147\/ndt.s301225","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}